1,303
Views
4
CrossRef citations to date
0
Altmetric
Review

Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19

ORCID Icon
Pages 186-198 | Received 14 Jun 2021, Accepted 03 Aug 2021, Published online: 10 Sep 2021

References

  • Lal H, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Eng. J. Med., 2015;372:2087–96.
  • Seow J et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infections in humans. Nature Microbiol. 2020;5: 1598–1607
  • Yuen KS et al. (2020). SARS-CoV-2 and Covid-19: The most important research questions. Cell & Bioscience 10: Article no. 40.
  • Tillett RL, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. The Lancet, 2021;21:52–58.
  • NORC (2020) Many remain doubtful about getting Covid-19 vaccine. NORC at the University of Chicago, Dec. 9, 2020.
  • Simmonds P (2020) Rampant C-U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses. mSphere, 2020;24: e00408
  • Lucas C et al (2020) Longitudinal analyses reveal immunological misfiring in severe Covid-19. Nature, 584: 463–469
  • Wadman M et al (2020) How does coronavirus kill? Science, April 17, 2020.
  • Broggi A et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science, 2020;369:706–712.
  • Zhang X, Sergin I, Evans TD, et al. High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat Metab 2. 2020;2(1):110–125. 2020.
  • Couzin-Frankel J (2020). The mystery of the pandemic's “happy hypoxia” Science 368: 455–466.
  • Knoepler PS (2019) Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years, Future Medicine, 2019:0064.
  • Johnson RC et al. Investigation of a cluster of Sphingomonas koreensis infections. N. Eng. J. Med. 2018;379: 2529–2539.
  • Nacoti M et al (2020) At the epicenter of the Covid-19 pandemic and humanitarian crisis in Italy. NEJM Catalyst, March 21, 2020.
  • Lednicky JA et al. Viable SARS-CoV-2 in the air of a hospital room with Covid-19 patients. Int. J. Infectious Diseases, 2020;100:476–482.
  • Goldacre B. Bad Pharma. Farrar, Strauss, and Giroux, 2013. New York, NY.
  • Onakpoya IJ et al. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions. BMC Med, 2016;14:10.
  • Rupp T et al. Quality of life, overall survival, and cost of cancer drugs approved based on surrogate endpoints. JAMA Intern. Med., 2017;177:276–277.
  • Garcia PJ. Corruption in global health: the open secret. Lancet, 2019;394: 2119–2124.
  • Hughes S et al. Differences in reporting serious adverse events in industry sponsored clinical trial registry and journal articles on antidepressant and antipsychotic drugs: a cross sectional study. BMJ Open 2014;4: e005535.
  • Fred HL. Dishonesty in medicine revisited. Texas Heart Inst. J, 2018;35:6–15.
  • George SL and Buyse M. Data fraud in clinical trials. Clinical investigation, 2015;5: 161–173.
  • Connor S. Glaxo chief: our drugs do not work on most patients. The Independent, Dec 8, 2003.
  • Patashnik E (2018) Why American doctors [sic] keep doing expensive procedures that don't work. Vox, Feb. 14, 2018.
  • Maguire G. Thinking and Eating for Two. Berkeley Free Speech Press, Berkeley, CA, 2018.
  • Maguire G. The safe and efficacious use of secretome from fibroblasts and adipose-derived (but not bone marrow-derived) mesenchymal stem cells for skin therapeutics. J Clin Aesthet Dermatol. 2019;12(8):E57–E69.
  • Maguire G, Friedman P. The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts. future science OA. In: Press; 2020:6(7):FSO592.
  • Sanchez-Guijo F et al.Adipose derived mesenchymal stem cells for the treatment of patients with severe Covid-19 pneumonia requiring mechanical ventilation. E Clinical Medicine 2020;25:100454.
  • Sharma D, Zhao F. Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19. Npj Regen Med. 2021;6(1):37.
  • Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Res Ther. 2021;12(1):1.
  • Wood WA, Krishnamurthy J, Mitin N, et al. Chemotherapy and stem cell transplantation increase p16INK4a expression, a biomarker of T-cell aging. EBioMedicine. 2016 Sep;11:227–238.
  • Akbar AN, Gilroy DW. Aging immunity may exacerbate COVID-19. Science. 2020;369(6501):256–257.
  • Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):241–248. .
  • Røsland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow–Derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009 July 1;69(13):5331–5339.
  • Liu C, Feng X, Wang B, et al. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin‐mediated phosphoinositide 3‐kinase/Akt/mammalian target of rapamycin. Cancer Sci. 2018;109(3):688–698. .
  • Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1–11.
  • Axelrod HD, Pienta KJ, Valkenburg KC, et al. (2018) optimization of immunofluorescent detection of bone marrow disseminated tumor cells. BMC Biological Procedures Online. 2018;20(1):13. .
  • Burns JS, Kristiansen M, Kristensen LP, et al. Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin‐1 dependent endothelial interaction. PLoS One. 2011;6(7):e21888. .
  • Kauer M, Ban J, Kofler R, et al. A molecular function map of Ewing’s sarcoma. PLoS One. 2009;4(4):e5415. .
  • Barzegar M, et al. Human placental mesenchymal stem cells derived exosome-angiotensin converting enzyme-2 dependent protection in ischemic stroke injury. Stem Cells 2021:1–14.
  • Khan G, et al. Exosomes and their role in viral infections. Intechopen. 2017. DOI:https://doi.org/10.5772/intechopen.69397.
  • McKelvey KJ, Powell KL, Ashton AW, et al. Exosomes: mechanisms of uptake. J Circ Biomark. 2015 Jan-Dec;4:7.
  • Smirnov SV, Harbacheuski R, Lewis-Antes A, et al. Bone marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology. 2007;360(1):6–16.
  • Avanzi S, Leoni V, Rotola A, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS One. 2013;8(8):e–71412. .
  • Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA. 2009;106(38):16357–16362.
  • Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187(7):751–760.
  • Esfandiyari R, Halabian R, Behzadi E, et al. Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells. Heliyon. 2019 Oct;5(10):e02652. .
  • Ahmed A, Siman-Tov G, Hall G, et al. Human antimicrobial peptides as therapeutics for viral infections. Viruses. 2019;11(8):704.
  • Hsieh IN, Hartshorn KL. The role of antimicrobial peptides in influenza virus infection and their potential as antiviral and immunomodulatory therapy. Pharmaceuticals (Basel). 2016 Sep;9(3):53.
  • Lazzaro BP, Zasloff M, Rolff J, et al. Antimicrobial peptides: application informed by evolution. Science. 2020;368(6490):eaau5480. .
  • Wu X, Dao Thi VL, Huang Y, et al. Intrinsic Immunity shapes viral resistance of stem cells. Cell. 2018;172(3):423–438.e425.
  • Qian X, Xu C, Fang S, et al. Exosomal MicroRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection. Stem Cells Transl Med. 2016;5(9):1190–1203.
  • Lin J, Kuo R-L, Huang H-I, et al. Activation of type I interferon antiviral response in human neural stem cells. Stem Cell Res Ther. 2019;10(1):387.
  • Yao Z, Qiao Y, Li X, et al. Exosomes exploit the virus entry machinery and pathway to transmit alpha interferon-induced antiviral activity. J Virol. 2018;92(24):e01578–18.
  • Deguchi H, Elias D, Navarro S, et al. Elevated serum amyloid A is associated with venous thromboembolism. Thromb Haemost. 2013;109(2):358–359. .
  • Magro C, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13.
  • Katsuda T, Tsuchiya R, Kosaka N, et al. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep. 2013;3(1):1197.
  • Miners JS, Barua N, Kehoe PG, et al. Aβ-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol. 2011;70(11):944–959.
  • Naik S, Larsen SB, Gomez NC, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550(7677):475–480. .
  • Lay K, Yuan S, Gur-Cohen S, et al. (2018) Stem cells repurpose proliferation to contain a breach in their niche barrier. eLife. 2018;7:e41661.
  • Hoelzinger DB, Smith SE, Mirza N, et al. Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol. 2010;184(12):6833‐6842.
  • Hong P, Yang H, Wu Y, et al. The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review. Stem Cell Res Ther. 2019;10(1):242.
  • Hong HE, Kim O-H, Kwak BJ, et al. Antioxidant action of hypoxic conditioned media from adipose-derived stem cells in the hepatic injury of expressing higher reactive oxygen species. Ann Surg Treat Res. 2019;97(4):159. .
  • Scharschmidt TC, Vasquez KS, Pauli ML, et al. Commensal microbes and hair follicle morphogenesis coordinately drive treg migration into neonatal skin. Cell Host Microbe. 2017;21(4):467‐477.e5.
  • García PJ. Corruption in global health: the open secret. Lancet. 2019;394(10214):2119–2124.
  • García-Contreras M, Vera-Donoso CD, Hernández-Andreu JM, et al. Therapeutic potential of human adipose-derived stem cells (ADSCs) from cancer patients: a pilot study. PLoS ONE. 2014;9(11):e113288. .
  • Kamada R, Yang W, Zhang Y, et al. Interferon stimulation creates chromatin marks and establishes transcriptional memory. Proc Nat Acad Sci USA. 2018;115(39):E9162–E9171. .
  • Than UT Guanzon D, Wager L, et al. (2018) An analysis of exosomes from keratinocytes and fibroblasts. 5th International Conference on Biomedical Engineering in Vietnam, 137 IFMBE Proceedings 46, Ho Chi Minh City. DOI: https://doi.org/10.1007/978-3-319-11776-8_34.
  • Trompette A, Gollwitzer ES, Pattaroni C, et al. Dietary fiber confers protection against flu by shaping Ly6c − patrolling monocyte hematopoiesis and CD8+ T cell metabolism. Immunity. 2018;48(5):992–1005. .
  • Aiello S, Rocchetta F, Longaretti L, et al. Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival. Sci Rep. 2017;7(1):11518.
  • Mitroulis I, Ruppova K, Wang B, et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell. 2018;172(1–2):147–161.e12.
  • Sterling P. What is health?: allostasis and the evolution of human design. Cambridge, MA: MIT Press; 2020.
  • Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832.
  • Rodrigues TS, se Sa KSG, Ishimoto AY, et al. Inflammasome activation in COVID-19 patients. medRxiv. 2020 Aug 6.
  • George PM, Wells AU, Jenkins RG, et al. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815.
  • Barnes PJ, Baker J, Donnelly LE. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am J Respir Crit Care Med. 2019;200(5):556–564.
  • Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362.
  • Tsuruhara A, Aso K, Tokuhara D, et al. Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells. Int Immunol. 2017;29(1):5–10.
  • Vonarburg C, Loetscher M, Spycher MO, et al. Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respir Res. 2019;20(1):99. .
  • Isho B, Abe KT, Zuo M, et al. Evidence for sustained mucosal and systemic antibody responses to SARSCoV-2 antigens in COVID-19 patients. medRxiv. 2020 August 4;2020.
  • Lukassen S, Chua RL, Trefzer T, et al. SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020;39:e105114.
  • Yu F, Jia R, Tang Y, et al. SARS-CoV-2 infection and stem cells: interaction and intervention. Stem Cell Res. 2020;46:101859.
  • Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10(1):173–194.
  • Banerjee A, Czinn SJ, Reiter RJ, et al. Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19. Life Sci. 2020;255:117842.
  • Maguire G. Transplanted stem cells survive a long time: do they make you sick? J Roy Soc Med. 2019;112(10):412–414.
  • Tutuncuoglu B, Cakir M, Batra J, et al. The landscape of human cancer proteins targeted by SARS-CoV-2. Cancer Discov. 2020;10(7):916–921.
  • Bouhaddou M,  Memon D, Meyer B, et al. The global phosphorylation landscape of SARSCoV-2 Infection. Cell. 2020;182:685–712.
  • Rajasurya V, Gunasekaran K, Damarla GK, et al. A fatal case of coronavirus disease 2019 (COVID-19) in a patient with idiopathic pulmonary fibrosis. Cureus. 2020;12(6):e8432.
  • Huang J, Hume AJ, Abo KM, et al. SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar Type 2 cells elicitsa rapid epithelial-intrinsic inflammatory response. Cell Stem Cell. 2020;27(6):1–12. .
  • Suzuki T, Itoh Y, Sakai Y, et al. Generation of human bronchial organoids for SARS-CoV-2 research. bioRxiv. 2020;5(25):115600.
  • Valyaeva AA,  Zharikova AA, Kasianov AF, et al. Lung epithelial stem cells express SARS-CoV-2 entry factors: implications for COVID-19. bioRxiv, May. 2020;23:2020.
  • Youk J, Kim T, Evans KV, et al. Three-Dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV2. Cell Stem Cell. 2020;27(6):905–919.e10.
  • Radwan SM, Ghoneim D, Salem M, et al. Adipose Tissue–derived mesenchymal stem cells protect against amiodarone-Induced lung injury in rats. Appl Biochem Biotechnol. 2020;191(3):1027–1041. .
  • Zhang Y, Jiang X, Ren L, et al. Optimization of the adipose-derived mesenchymal stem cell delivery time for radiation-induced lung fibrosis treatment in rats. Sci Rep. 2019;9(1):5589. .
  • Fox SE, Li G, Akmatbekov A, et al. Unexpected features of cardiac pathology in COVID-19 infection. Circulation. 2020;142(11):1123–1125.
  • Puntmann VO Carerj ML, Wieters M, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published online July 27, 2020. doi:https://doi.org/10.1001/jamacardio.2020.3557.
  • Bruun K, Schermer E, Sivendra A, et al. Therapeutic applications of adipose-derived stem cells in cardiovascular disease. Am J Stem Cells. 2018;7(4):94–103.
  • Guo Y, Yu Y, Hu S, et al. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020;11(5):349.
  • Coppin L, Sokal E, Stéphenne X. Thrombogenic risk induced by intravascular mesenchymal stem cell therapy: current status and future perspectives. Cells. 2019;8(10):1160.
  • Netsch P, Elvers-Hornung S, Uhlig S, et al. Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine. Stem Cell Res Ther. 2018;9(1):184.
  • Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283–288. .
  • Rojas OL, Pröbstel AK, Porfilio EA, et al. Recirculating Intestinal IgA-Producing cells regulate neuroinflammation via IL-10. Cell. 2019;176(3):610–624.e18.
  • De Bruljn S, Maes MB, De Waele L, et al. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thrombosis Haemostasis. 2021. DOI:https://doi.org/10.1111/jth.15418.
  • Prüss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021. DOI:https://doi.org/10.1038/s41577-021-00543-w
  • Che N, Li X, Zhang L, et al. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression. J Immunol. 2014 Nov 15;193(10):5306–5314.
  • Li W, Chen W, Sun L. An update for mesenchymal stem cell therapy in lupus nephritis. Kidney Dis. 2021;7(2):79–89.
  • Peta I, Fraussen J, Somers V, et al. Interrelation of Diet, gut microbiome, and autoantibody production. Front Immunol. 2018;9:439.
  • Sanchez HN, Moroney JB, Gan H, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat Commun. 2020;11(1):60. .
  • Fuchs E, Blau HM. Tissue stem cells: architects of their niches. Cell Stem Cell. 2020;27(4):532–556.
  • Brendan O, Mojgan R. The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front Genet. 2012;3:81.
  • Wolock SL, Krishnan I, Tenen DE, et al. Mapping distinct bone marrow niche populations and their differentiation paths. Cell Rep. 2019;28(2):302–311.e5. .
  • Sai B, Xiang J. Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy. J Cell Mol Med. 2018;22(12):5776–5786.
  • Freisenger E, Cramer C, Xia X, et al. Characterization of hematopoietic potential of mesenchymal stem cells. J Cell Physiol. 2010;225(3):888–897. .
  • Cardenas C, Kwon J-Y, Maeng Y-S, et al. Human cord blood-derived CD133+/C-Kit+/Lin−Cells have bipotential ability to differentiate into mesenchymal stem cells and outgrowth endothelial cells. Stem Cell Intl. Article ID 7162160 | 12 pages 2016;2016: 1–12.
  • Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133‐positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2009;23(8):1105–1112. .
  • Chong P, Selvaratnam L, Abbas AA, et al. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res. 2011;30(4):634–642. .
  • Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25(7):1737‐1745. .
  • Sai B, Dai Y, Fan S, et al. Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs. Cell Death Dis. 2019;10(12):941. .
  • Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315‐1321. .
  • Ma Z, Ma Z, Cui X, et al. RETRACTED ARTICLE: exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis. Stem Cell Res Ther. 2019;10(1):60. .
  • Rocken M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J Clin Invest. 2010 Jun 1;120(6):1800–1803.
  • Tjensvoll K, Nordgård O, Skjæveland M, et al. Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients. BMC Cancer. 2019;19(1):1131. .
  • Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416(6880):542–545. (2002).
  • Nakata R, Shimada H, Fernandez GE, et al. Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells. J Extracell Vesicles. 2017;6(1):1332941. .
  • Noubissi FK, Harkness T, Alexander CM, et al. Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis. FASEB J. 2015;29(9):4036–4045. .
  • Chitwood CA, Dietzsch C, Jacobs G, et al. Breast tumor cell hybrids form spontaneously in vivo and contribute to breast tumor metastases. APL Bioeng. 2018;2(3):31907. .
  • Li H, FENG Z, TSANG TC, et al. Fusion of HepG2 cells with mesenchymal stem cells increases cancer associated and malignant properties: an in vivo metastasis model. Oncol Rep. 2014;32(2):539–547. .
  • Medyouf H, Mossner M, Jann J-C, et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014;14(6):824–837. .
  • Conese M, Annacontini L, Carbone A, et al. The role of adipose-Derived stem cells, dermal regenerative templates, and Platelet-Rich plasma in tissue engineering-based treatments of chronic skin wounds. Stem Cell Intl. V 2020 |Article ID 7056261 | 17 pages 2020;2020: 1–17.
  • Burrow KL, Hoyland JA, Richardson SM, et al. Human Adipose-Derived stem cells exhibit enhanced proliferative capacity and retain multipotency longer than donor-matched bone marrow mesenchymal stem cells during expansion in vitro. Stem Cells Int. Article ID 2541275 2017;2017: 15.
  • Campisi J, Andersen JK, Capahi P, et al. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol. 2011;21(6):354–359.
  • Mazzola RF, Mazzola IC. The fascinating history of fat grafting. J Craniofacial Surgery. 2013;24(4):1069–1071.
  • Agostini T, Lazzeri D, Pini A, et al. Wet and dry techniques for structural fat graft harvesting: histomorphometric and cell viability assessments of lipoaspirated samples. Plast Reconstr Surg. 2012;130(2):331e‐339e. .
  • Raj S, Abu-Ghname A, Davis MJ, et al. Safety and regulation of fat grafting. Semin Plast Surg. 2020;34(1):59–64. .
  • Zielins ER, Brett EA, Longaker MT, et al. (2016) autologous fat grafting: the science behind the surgery. Aesthet Surg J. 2016 Apr;36(4):488–496. .
  • Toyserkani NM, Jensen CH, Tabatabaeifar S, et al. Adipose-derived regenerative cells and fat grafting for treating breast cancer-related lymphedema: lymphoscintigraphic evaluation with 1 year of follow-up. J Plast Reconstr Aesthet Surg. 2019;72(1):71‐77.
  • Moon KC, Suh HS, Kim KB, et al. Potential of allogeneic adipose-derived stem Cell-Hydrogel complex for treating diabetic foot ulcers. Diabetes. 2019;68(4):837‐846.
  • Rigotti G, Marchi A, Galie M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007;119(5):1409–1422. .
  • Kim H, Hyun MR, Kim SW, et al. The effect of Adipose-Derived stem cells on wound healing: comparison of methods of application. Stem Cell Intl. Vkim 2019 |Article ID 2745640 | 8 pages 2019;2019: 1–8.
  • Zomer HD, Jeremias TDS, Ratner B, et al. Mesenchymal stromal cells from dermal and adipose tissues induce macrophage polarization to a pro-repair phenotype and improve skin wound healing. Cytotherapy. 2020;22(2020):247260. .
  • Mitchell R, Mellows B, Sheard J, et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther. 2019;10(1):116. .
  • Rogers CJ, Harman RJ, Bunnell BA, et al. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020;18:203.
  • Mehta DR, Ashkar AA, Mossman KL. The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts. PloS One. 2012;7(2):e31688.
  • van Asten SD, Raaben M, Nota B, et al. Secretome screening reveals fibroblast growth factors as novel inhibitors of viral replication. J Virology. 2018;92(16):e00260–18.
  • Sánchez-Guijo F, Garcia-Arranz M, Lopez-parra M, et al. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinical Medicine, m5G. 2020 July 4;6:30.
  • Dinnon KH, Leist SR, Schafer A, et al. A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures. bioRxiv. 2020. DOI:https://doi.org/10.1101/2020.05.06.081497.
  • Du RH, Richmond BW, Blackwell TS Jr, et al. (2015) Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease. Virchows Arch. 2015;467(6):657–665. .
  • Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol. 2020;20(6):339–341.
  • Hu Y, Qin C, Zheng G, et al. Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced systemic response. Mediators Inflamm. |Article ID 3735452 | 12 pages 2016;2016: 1–12.
  • Fraikin JL, Teesalu T, McKenney CM, et al. A high-throughput label-free nanoparticle analyser. Nat Nanotechnol. 2011;6(5):308–313.
  • Spencer CN Gopalakrishnan V, McQuade J, et al. (2019) The gut microbiome (GM) and immunotherapy response are influenced by host lifestyle factors. AACR Annual Meeting, PO.TB06.09 - Inflammation and Microbiome, 2838/24.
  • Maguire G. Systems biology approach to developing “systems therapeutics. ACS Med Chem Lett. 2014;5(5):453–455.
  • Maguire G. Physiological renormalization using systems therapeutics. Future Sci OA. 2020 Jan;6(1):FSO428.
  • Maguire G (2020) Better preventing and mitigating the effects of covid-19. Future Science OA, FSO586.
  • Mihaylova MM, Sabatini D, Yilmaz Ö, et al. Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell. 2014;14(3):292–305. .
  • Zhang Y, Wang D, Lin M, et al. Serum amyloid a protein as a potential biomarker useful in monitoring the course of COVID-19: a retrospectively studied. Res Square. 2020. DOI:https://doi.org/10.21203/rs.3.rs-19724/v1.
  • King JS. Mechanical stress meets autophagy: potential implications for physiology and pathology. Trends Mol Med. 2012;18(10):583–588.
  • Villanueva C, Kross RD. Antioxidant-induced stress. Int J Mol Sci. 2012;13(2):2091–2109.
  • Beck MA. Antioxidants and viral infections: host immune response and viral pathogenicity. J Am Coll Nutr. 2001;20(5):384S–388S.
  • Crump KE, Langston PK, Rajkarnikar S, et al. Antioxidant treatment regulates the humoral immune response during acute viral infection. J Virology. 2013;87(5):2577–2586.
  • Rajaram S. Health benefits of plant-derived α-linolenic acid. Am J Clin Nutr. 2014;100(suppl_1):443S–448S.
  • Liu YX, Zhu KY, Liu YL, et al. Effects of dietary conjugated linoleic acids on cellular immune response of piglets after cyclosporin A injection. Animal. 2016;10(10):1660–1665. .
  • Chiang YL, Haddad E, Rajaram S, et al. The effect of dietary walnuts compared to fatty fish on eicosanoids, cytokines, soluble endothelial adhesion molecules and lymphocyte subsets: a randomized, controlled crossover trial. Prostaglandins Leukot Essent Fatty Acids. 2012;87(4–5):111–117. .
  • Wheelock CE, Rapapport SM. The role of gene–environment interactions in lung disease: the urgent need for the exposome. Euro Resp J. 2020;55(2):1902064.